Literature DB >> 6461451

Hypocomplementaemia due to a genetic deficiency of beta 1H globulin.

R A Thompson, M H Winterborn.   

Abstract

An 8-month-old Asian boy who presented with the haemolytic uraemic syndrome was found to have a low haemolytic complement, and in particular a very low C3 level, with a normal C4 level. These abnormalities persisted after recovery and were not associated with the presence of circulating C3 nephritic factor. A clinically healthy 3-year-old brother was found to have an identical complement profile, which indicated increased alternative pathway activation. Both brothers had normal levels of the C3b inactivator, but very low levels of beta 1H globulin (less than 10% of a reference standard serum). The parents, who were first cousins, had half-normal levels of beta 1H globulin, and low levels were found in other members of the family, indicating that the defect was inherited.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6461451      PMCID: PMC1536333     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator.

Authors:  K Whaley; S Ruddy
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

3.  The presence of donor-type immunoglobulins in anaemic mice of the W-series transplanted with allogeneic foetal liver cells.

Authors:  M J Seller
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

4.  Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3.

Authors:  C A Alper; K J Bloch; F S Rosen
Journal:  N Engl J Med       Date:  1973-03-22       Impact factor: 91.245

Review 5.  The hemolytic uremic syndrome.

Authors:  B S Kaplan; P D Thomson; J P de Chadarévian
Journal:  Pediatr Clin North Am       Date:  1976-11       Impact factor: 3.278

6.  Recurrent hemolytic-uremic syndrome: a case report.

Authors:  A Drukker; M Winterborn; B Bennett; J Churg; A Spitzer; I Greifer
Journal:  Clin Nephrol       Date:  1975-08       Impact factor: 0.975

7.  Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.

Authors:  J A Charlesworth; D G Williams; E Sherington; P J Lachmann; D K Peters
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

8.  Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.

Authors:  R A Thompson; P J Lachmann
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

9.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  59 in total

1.  The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion.

Authors:  Guido A Hegasy; Tamara Manuelian; Kolbjorn Hogasen; Johan H Jansen; Peter F Zipfel
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Polymorphism and deficiency of human factor H-related proteins p39 and p37.

Authors:  E Feifel; W M Prodinger; M Mölgg; W Schwaeble; D Schönitzer; V Koistinen; R Misasi; M P Dierich
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 3.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Familial, recurrent haemolytic-uraemic syndrome with hypocomplementaemia.

Authors:  J Zachwieja; K Strzykala; W Golda; J Maciejewski
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

5.  Properdin homeostasis requires turnover of the alternative complement pathway.

Authors:  Xiaobo Wu; Thomas Q Xu; John P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

6.  Hemolytic uremic syndrome due to homozygous factor H deficiency.

Authors:  Sidharth Kumar Sethi; Dragon-Durey Marie-Agnes; Neelam Thaker; Pankaj Hari; Arvind Bagga
Journal:  Clin Exp Nephrol       Date:  2009-07-01       Impact factor: 2.801

Review 7.  From compliment to insult: genetics of the complement system in physiology and disease in the human retina.

Authors:  Robert F Mullins; Alasdair N Warwick; Elliott H Sohn; Andrew J Lotery
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

Review 8.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

Review 9.  Advances and challenges in the management of complement-mediated thrombotic microangiopathies.

Authors:  Jean-Claude Davin; Nicole C A J van de Kar
Journal:  Ther Adv Hematol       Date:  2015-08

Review 10.  aHUS caused by complement dysregulation: new therapies on the horizon.

Authors:  Aoife M Waters; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-06-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.